Correlation Between Fubon MSCI and Medigen Vaccine

Can any of the company-specific risk be diversified away by investing in both Fubon MSCI and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fubon MSCI and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fubon MSCI Taiwan and Medigen Vaccine Biologics, you can compare the effects of market volatilities on Fubon MSCI and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fubon MSCI with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fubon MSCI and Medigen Vaccine.

Diversification Opportunities for Fubon MSCI and Medigen Vaccine

-0.47

Correlation Coefficient

Fubon MSCI  Medigen Vaccine

Very good diversification

The 3 months correlation between Fubon and Medigen is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Fubon MSCI Taiwan and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and Fubon MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fubon MSCI Taiwan are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of Fubon MSCI i.e., Fubon MSCI and Medigen Vaccine go up and down completely randomly.

Pair Corralation between Fubon MSCI and Medigen Vaccine

Assuming the 90 days trading horizon Fubon MSCI Taiwan is expected to under-perform the Medigen Vaccine. But the etf apears to be less risky and, when comparing its historical volatility, Fubon MSCI Taiwan is 2.61 times less risky than Medigen Vaccine. The etf trades about -0.1 of its potential returns per unit of risk. The Medigen Vaccine Biologics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  3,715  in Medigen Vaccine Biologics on December 28, 2024 and sell it today you would earn a total of  1,495  from holding Medigen Vaccine Biologics or generate 40.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.21%
Values	Daily Returns

Fubon MSCI Taiwan  vs.  Medigen Vaccine Biologics

Fubon MSCI Taiwan

Risk-Adjusted Performance

Very Weak

Over the last 90 days Fubon MSCI Taiwan has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Etf's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the fund sophisticated investors.

Medigen Vaccine Biologics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Vaccine Biologics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Fubon MSCI and Medigen Vaccine

The main advantage of trading using opposite Fubon MSCI and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fubon MSCI position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.

The idea behind Fubon MSCI Taiwan and Medigen Vaccine Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.